marketcaparena
Search

    CHRS

    Coherus Oncology, Inc.

    Company overview

    Market capitalization
    $176.13M
    Employees
    145
    Latest publication
    2026-09-29
    About Coherus Oncology, Inc.

    Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin IL-27. It also develops CHS-114, an investigational human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME) patients with head and neck squamous cell carcinoma. It has a collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreements with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc. and Surface and Vaccinex, Inc.; and out-licensing agreement with Novartis Institutes for Biomedical Research, Inc. and GlaxoSmithKline Intellectual Property No. 4 Limited. It also has a clinical collaboration agreement with Zumutor Biologics Inc. for the development of LOQTORZI with ZM0008 as a treatment for cancer patients. The company was formerly known as Coherus BioSciences, Inc. and changed its name to Coherus Oncology, Inc. in May 2025. The company was incorporated in 2010 and is based in Redwood City, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20202020-12-31 · USDQ3 20202020-09-30 · USDQ2 20202020-06-30 · USDQ1 20202020-03-31 · USDQ4 20192019-12-31 · USDQ3 20192019-09-30 · USDQ2 20192019-06-30 · USD
    Total Revenue14,307,000USD110,419,000USD113,551,000USD135,674,000USD116,180,000USD123,856,000USD111,684,000USD83,433,000USD
    Cost Of Revenue4,242,000USD11,673,000USD9,000,000USD10,139,000USD6,855,000USD7,805,000USD6,447,000USD601,000USD
    Gross Profit10,065,000USD98,746,000USD104,551,000USD125,535,000USD109,325,000USD116,051,000USD105,237,000USD82,832,000USD
    Research Development21,442,000USD44,628,000USD38,851,000USD26,173,000USD33,107,000USD34,948,000USD21,568,000USD18,883,000USD
    Selling General Administrative20,954,000USD33,893,000USD31,984,000USD34,052,000USD35,350,000USD31,570,000USD31,828,000USD36,456,000USD
    Total Operating Expenses42,396,000USD82,321,000USD70,835,000USD60,225,000USD68,457,000USD71,018,000USD53,396,000USD55,339,000USD
    Operating Income-32,331,000USD16,425,000USD33,716,000USD65,310,000USD40,868,000USD45,033,000USD51,841,000USD27,493,000USD
    Total Other Income Expense Net-1,016,000USD-5,665,000USD-5,600,000USD-4,985,000USD-4,363,000USD-3,762,000USD-3,951,000USD-3,875,000USD
    Interest Expense2,323,000USD5,671,000USD5,656,000USD5,408,000USD4,431,000USD4,483,000USD4,469,000USD4,433,000USD
    Income Before Tax-33,347,000USD10,760,000USD28,116,000USD60,325,000USD36,505,000USD41,271,000USD47,890,000USD23,618,000USD
    Income Tax Expense0USD1,052,000USD183,000USD1,294,000USD933,000USD2,044,000USD847,000USD51,000USD
    Discontinued Operations12,716,000USD———————
    Net Income-20,631,000USD9,708,000USD27,933,000USD59,031,000USD35,572,000USD39,227,000USD47,043,000USD23,567,000USD
    Selling And Marketing Expenses—3,800,000USD———4,500,000USD——
    Net Interest Income—-5,671,000USD-5,656,000USD-5,408,000USD-4,431,000USD-4,483,000USD-4,469,000USD-4,433,000USD
    Tax Provision—1,052,000USD183,000USD1,294,000USD933,000USD2,044,000USD847,000USD51,000USD
    Net Income From Continuing Ops—9,708,000USD27,933,000USD59,031,000USD35,572,000USD39,227,000USD47,043,000USD23,567,000USD
    Ebit—16,431,000USD33,772,000USD65,733,000USD40,936,000USD45,754,000USD52,359,000USD27,493,000USD
    Ebitda—17,271,000USD34,465,000USD66,481,000USD41,543,000USD46,809,000USD53,198,000USD28,167,000USD
    Depreciation And Amortization—840,000USD693,000USD748,000USD607,000USD1,055,000USD839,000USD674,000USD
    Reconciled Depreciation—840,000USD693,000USD748,000USD607,000USD1,055,000USD839,000USD674,000USD
    Non Operating Income Net Other—7,000USD56,000USD423,000USD68,000USD—518,000USD558,000USD
    Net Income Applicable To Common Shares—9,708,000USD27,933,000USD59,031,000USD35,572,000USD39,227,000USD47,043,000USD23,567,000USD
    Interest Income————4,431,000USD4,483,000USD4,469,000USD4,433,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue475,824,000USD356,071,000USD190,106,000USD
    Cost Of Revenue37,667,000USD17,078,000USD254,440,000USD
    Gross Profit438,157,000USD338,993,000USD-64,334,000USD
    Research Development142,759,000USD94,188,000USD254,440,000USD
    Selling General Administrative135,279,000USD132,537,000USD51,597,000USD
    Selling And Marketing Expenses3,800,000USD4,500,000USD—
    Total Operating Expenses281,838,000USD231,225,000USD306,037,000USD
    Operating Income156,319,000USD107,768,000USD-115,931,000USD
    Interest Expense21,166,000USD17,601,000USD7,980,000USD
    Net Interest Income-21,166,000USD-17,601,000USD-7,980,000USD
    Income Before Tax135,707,000USD92,775,000USD-127,788,000USD
    Income Tax Expense3,463,000USD2,942,000USD656,000USD
    Tax Provision3,463,000USD2,942,000USD—
    Net Income132,244,000USD89,833,000USD-127,337,000USD
    Net Income From Continuing Ops132,244,000USD89,833,000USD-127,788,000USD
    Ebit156,873,000USD107,768,000USD-119,808,000USD
    Ebitda161,842,000USD111,027,000USD-116,812,000USD
    Depreciation And Amortization4,969,000USD3,259,000USD2,996,000USD
    Reconciled Depreciation2,888,000USD3,259,000USD—
    Total Other Income Expense Net-20,612,000USD-14,993,000USD-11,857,000USD
    Non Operating Income Net Other554,000USD2,608,000USD-3,877,000USD
    Minority Interest0USD0USD-1,173,000USD
    Net Income Applicable To Common Shares132,244,000USD89,833,000USD-127,337,000USD
    Interest Income—17,601,000USD7,980,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets191,183,000USD266,022,000USD258,343,000USD516,519,000USD439,464,000USD371,066,000USD448,533,000USD505,000,000USD
    Cash And Equivalents82,923,000USD———————
    Cash And Short Term Investments105,306,000USD167,048,000USD172,125,000USD191,663,000USD237,637,000USD82,411,000USD125,987,000USD97,690,000USD
    Short Term Investments22,383,000USD51,810,000USD83,246,000USD88,311,000USD20,744,000USD—0USD0USD
    Total Current Assets133,788,000USD206,035,000USD206,706,000USD460,955,000USD380,205,000USD310,175,000USD341,583,000USD369,024,000USD
    Other Current Assets5,354,000USD11,652,000USD12,991,000USD16,748,000USD18,416,000USD161,810,000USD23,168,000USD24,894,000USD
    Other Non Current Assets3,116,000USD———————
    Total Liabilities130,345,000USD———————
    Total Current Liabilities75,510,000USD132,332,000USD141,876,000USD373,787,000USD265,119,000USD255,042,000USD282,981,000USD295,566,000USD
    Other Current Liabilities14,851,000USD———————
    Other Non Current Liabilities17,588,000USD———————
    Total Stockholder Equity60,838,000USD78,623,000USD61,014,000USD87,774,000USD119,827,000USD-183,470,000USD-131,990,000USD-87,973,000USD
    Total Equity Including Noncontrolling Interest60,838,000USD———————
    Inventory5,667,000USD4,825,000USD3,172,000USD2,048,000USD4,513,000USD3,518,000USD70,094,000USD47,640,000USD
    Property Plant Equipment Net865,000USD1,094,000USD1,345,000USD1,633,000USD1,907,000USD2,256,000USD2,837,000USD2,911,000USD
    Accounts Payable13,168,000USD11,479,000USD9,915,000USD24,893,000USD37,622,000USD40,930,000USD28,456,000USD21,893,000USD
    Common Stock15,000USD15,000USD12,000USD12,000USD12,000USD12,000USD12,000USD12,000USD
    Retained Earnings-1,441,927,000USD-1,421,296,000USD-1,382,969,000USD-1,345,326,000USD-1,309,795,000USD-1,607,562,000USD-1,550,993,000USD-1,500,297,000USD
    Accumulated Other Comprehensive Income-281,000USD-268,000USD-195,000USD-203,000USD-275,000USD-275,000USD-275,000USD-275,000USD
    Intangible Assets—45,614,000USD46,239,000USD49,484,000USD52,312,000USD52,979,000USD53,646,000USD54,313,000USD
    Total Liab—187,399,000USD197,329,000USD428,745,000USD319,637,000USD554,536,000USD580,523,000USD592,973,000USD
    Other Current Liab—118,954,000USD130,133,000USD347,103,000USD225,741,000USD212,389,000USD252,834,000USD272,044,000USD
    Capital Stock—15,000USD12,000USD12,000USD12,000USD12,000USD12,000USD12,000USD
    Other Assets—16,783,000USD18,992,000USD———-6,316,000USD—
    Cash—115,238,000USD88,879,000USD103,352,000USD216,893,000USD82,411,000USD125,987,000USD97,690,000USD
    Net Debt—-60,866,000USD-48,543,000USD-62,658,000USD-175,864,000USD187,516,000USD143,917,000USD172,185,000USD
    Short Term Debt—1,899,000USD1,828,000USD1,791,000USD1,756,000USD1,723,000USD1,691,000USD1,629,000USD
    Short Long Term Debt Total—54,372,000USD40,336,000USD40,694,000USD41,029,000USD269,927,000USD269,904,000USD269,875,000USD
    Long Term Debt—37,147,000USD37,051,000USD36,957,000USD36,867,000USD265,350,000USD264,927,000USD264,509,000USD
    Net Receivables—22,510,000USD18,418,000USD250,496,000USD119,639,000USD62,436,000USD122,334,000USD198,800,000USD
    Common Stock Shares Outstanding—136,398,303shares120,369,638shares116,229,170shares116,077,710shares115,857,780shares115,418,069shares115,210,091shares
    Non Current Assets Total—59,986,999USD51,637,000USD55,564,000USD59,259,000USD60,891,000USD106,950,000USD135,976,000USD
    Non Current Liabilities Total—55,067,000USD55,453,000USD54,958,000USD54,518,000USD299,494,000USD297,542,000USD297,407,000USD
    Non Current Liabilities Other—14,374,000USD15,843,000USD14,953,000USD14,143,000USD30,188,000USD28,227,000USD28,059,000USD
    Non Currrent Assets Other—13,278,999USD4,053,000USD4,447,000USD5,040,000USD5,656,000USD50,467,000USD78,752,000USD
    Net Working Capital—72,213,000USD64,830,000USD87,168,000USD115,086,000USD55,133,000USD58,602,000USD73,458,000USD
    Unclassified Non Current Assets—-16,783,000USD-18,992,000USD—————
    Unclassified Non Current Liabilities—3,546,000USD2,559,000USD3,048,000USD3,508,000USD3,956,000USD4,388,000USD4,839,000USD
    Unclassified Equity—1,500,157,000USD1,444,154,000USD1,433,279,000USD1,429,873,000USD1,424,343,000USD1,419,254,000USD1,412,575,000USD
    Property Plant Equipment Gross——16,578,000USD20,969,000USD20,965,000USD23,624,000USD23,825,000USD23,533,000USD
    Good Will——————0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets258,343,000USD448,533,000USD629,604,000USD480,847,000USD679,334,000USD841,649,000USD408,927,000USD99,467,000USD
    Intangible Assets46,239,000USD53,646,000USD70,730,000USD4,988,000USD2,620,000USD2,620,000USD2,620,000USD2,620,000USD
    Other Current Assets12,991,000USD23,168,000USD34,756,000USD40,798,000USD24,464,000USD25,042,000USD13,542,000USD10,418,000USD
    Total Liab197,329,000USD580,523,000USD823,029,000USD618,265,000USD581,608,000USD560,675,000USD303,713,000USD138,058,000USD
    Total Stockholder Equity61,014,000USD-131,990,000USD-193,425,000USD-137,418,000USD97,726,000USD280,974,000USD105,214,000USD-38,591,000USD
    Other Current Liab130,133,000USD252,834,000USD294,407,000USD122,850,000USD145,676,000USD127,320,000USD88,984,000USD17,967,000USD
    Common Stock12,000USD12,000USD11,000USD8,000USD7,000USD7,000USD7,000USD7,000USD
    Capital Stock12,000USD12,000USD11,000USD8,000USD7,000USD7,000USD7,000USD7,000USD
    Retained Earnings-1,382,969,000USD-1,550,993,000USD-1,579,500,000USD-1,341,608,000USD-1,049,854,000USD-762,754,000USD-894,998,000USD-984,831,000USD
    Other Assets18,992,000USD——64,151,000USD45,865,000USD60,499,000USD45,866,000USD4,811,000USD
    Cash88,879,000USD125,987,000USD102,891,000USD63,547,000USD417,195,000USD541,158,000USD177,668,000USD72,356,000USD
    Cash And Short Term Investments172,125,000USD125,987,000USD117,748,000USD191,681,000USD417,195,000USD541,158,000USD177,668,000USD72,356,000USD
    Total Current Assets206,706,000USD341,583,000USD475,631,000USD381,234,000USD602,323,000USD767,479,000USD374,731,000USD72,356,000USD
    Total Current Liabilities141,876,000USD282,981,000USD331,771,000USD138,694,000USD165,327,000USD145,653,000USD114,969,000USD33,261,000USD
    Net Debt-48,543,000USD143,917,000USD377,951,000USD416,875,000USD1,828,000USD-124,055,000USD718,000USD30,736,000USD
    Short Term Debt1,828,000USD1,691,000USD2,145,000USD4,318,000USD3,492,000USD3,132,000USD2,196,000USD—
    Short Long Term Debt Total40,336,000USD269,904,000USD480,842,000USD480,422,000USD419,023,000USD417,103,000USD180,582,000USD103,092,000USD
    Long Term Debt37,051,000USD264,927,000USD473,369,000USD225,575,000USD408,280,000USD377,395,000USD178,386,000USD103,092,000USD
    Short Term Investments83,246,000USD0USD14,857,000USD128,134,000USD0USD———
    Net Receivables18,418,000USD122,334,000USD260,522,000USD109,964,000USD123,022,000USD157,046,000USD141,992,000USD-1,742,000USD
    Inventory3,172,000USD70,094,000USD62,605,000USD38,791,000USD37,642,000USD44,233,000USD55,071,000USD1,659,000USD
    Accounts Payable9,915,000USD28,456,000USD35,219,000USD11,526,000USD16,159,000USD15,201,000USD25,985,000USD15,294,000USD
    Property Plant Equipment Net1,345,000USD2,837,000USD5,119,000USD8,754,000USD7,813,000USD10,108,000USD16,489,000USD6,660,000USD
    Property Plant Equipment Gross16,578,000USD23,825,000USD25,770,000USD28,911,000USD24,662,000USD20,064,000USD16,489,000USD6,660,000USD
    Accumulated Other Comprehensive Income-195,000USD-275,000USD-248,000USD-249,000USD-270,000USD-270,000USD-558,000USD-282,000USD
    Common Stock Shares Outstanding120,369,638shares114,830,462shares94,162,637shares77,630,020shares75,449,632shares83,491,898shares73,185,943shares65,034,827shares
    Non Current Assets Total51,637,000USD106,950,000USD153,973,000USD99,613,000USD77,011,000USD74,170,000USD34,196,000USD27,111,000USD
    Non Current Liabilities Total55,453,000USD297,542,000USD491,258,000USD479,571,000USD416,281,000USD415,022,000USD303,713,000USD138,058,000USD
    Non Current Liabilities Other15,843,000USD28,227,000USD11,459,000USD253,996,000USD94,301,000USD37,627,000USD102,000USD1,705,000USD
    Non Currrent Assets Other4,053,000USD50,467,000USD77,181,000USD84,928,000USD65,635,000USD60,499,000USD14,144,000USD16,888,000USD
    Net Working Capital64,830,000USD58,602,000USD143,860,000USD242,540,000USD554,442,000USD621,826,000USD228,040,000USD51,172,000USD
    Unclassified Non Current Assets-18,992,000USD——-64,151,000USD-45,865,000USD-60,499,000USD-45,866,000USD-4,811,000USD
    Unclassified Non Current Liabilities2,559,000USD4,388,000USD6,430,000USD—-180,601,000USD-75,123,000USD125,123,000USD31,556,000USD
    Unclassified Equity1,444,154,000USD1,419,254,000USD1,386,301,000USD1,204,423,000USD1,147,836,000USD1,043,984,000USD1,000,756,000USD946,508,000USD
    Good Will—0USD943,000USD943,000USD943,000USD943,000USD943,000USD943,000USD
    Other Liab———3,467,000USD94,301,000USD75,123,000USD102,000USD1,705,000USD
    Net Tangible Assets———-143,349,000USD97,726,000USD277,411,000USD101,651,000USD-42,154,000USD
    Current Deferred Revenue————-86,300,000USD-3,133,000USD-2,196,000USD—
    Unclassified Current Assets——————-13,542,000USD-12,077,000USD
    Unclassified Current Liabilities——————-2,196,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-37,939,000USD241,198,000USD-35,531,000USD297,767,000USD-56,569,000USD-50,696,000USD-10,751,000USD-54,851,000USD
    Depreciation881,000USD2,062,000USD966,000USD1,016,000USD1,046,000USD1,033,000USD1,549,000USD1,187,000USD
    Stock Based Compensation2,385,000USD10,793,000USD3,389,000USD5,421,000USD5,372,000USD6,384,000USD6,868,000USD7,231,000USD
    Other Non Cash Items468,000USD-260,976,000USD-5,774,000USD-327,184,000USD13,466,000USD17,349,000USD1,848,000USD39,134,000USD
    Change To Account Receivables-4,282,000USD106,161,000USD-4,266,000USD55,270,000USD50,891,000USD56,326,000USD7,807,000USD76,638,000USD
    Change To Inventory-11,312,000USD-18,474,000USD2,480,000USD3,770,000USD-22,244,000USD-6,453,000USD-6,942,000USD-7,102,000USD
    Change In Working Capital-23,681,000USD-12,793,000USD-9,389,000USD-23,652,000USD10,859,000USD54,538,000USD-61,530,000USD74,264,000USD
    Total Cash From Operating Activities-57,886,000USD-19,716,000USD-46,339,000USD-46,632,000USD-25,826,000USD28,608,000USD-62,016,000USD59,734,000USD
    Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
    Free Cash Flow-57,886,000USD-19,716,000USD-46,339,000USD-46,632,000USD-25,826,000USD28,608,000USD-62,016,000USD59,734,000USD
    Investments31,747,000USD5,550,000USD-67,227,000USD462,638,000USD-17,486,000USD-542,000USD444,000USD27,656,000USD
    Total Cashflows From Investing Activities30,655,000USD-2,838,000USD-67,227,000USD462,638,000USD-17,486,000USD-542,000USD444,000USD27,656,000USD
    Total Cash From Financing Activities53,590,000USD8,081,000USD2,000USD-281,524,000USD-264,000USD231,000USD-167,000USD-187,925,000USD
    Issuance Of Capital Stock53,650,000USD7,894,000USD0USD0USD0USD0USD0USD-52,000USD
    Change In Cash26,359,000USD-14,473,000USD-113,564,000USD134,482,000USD-43,576,000USD28,297,000USD-61,739,000USD-100,534,999USD
    Begin Period Cash Flow88,879,000USD103,592,000USD217,156,000USD82,674,000USD126,250,000USD97,953,000USD159,692,000USD259,774,999USD
    End Period Cash Flow115,238,000USD89,119,000USD103,592,000USD217,156,000USD82,674,000USD126,250,000USD97,953,000USD159,240,000USD
    Other Cashflows From Investing Activities-1,092,000USD-8,388,000USD-27,000USD483,364,000USD-17,486,000USD-542,000USD444,000USD27,656,000USD
    Other Cashflows From Financing Activities-60,000USD22,000USD2,000USD-48,527,000USD-264,000USD221,943,000USD-221,979,000USD34,709,000USD
    Net Borrowings—-47,652,000USD0USD——0USD-141,000USD—
    Sale Purchase Of Stock—-264,000USD264,000USD—-264,000USD-10,000USD-10,000USD-1,711,000USD
    Unclassified Financing Cash Flow—55,975,000USD—-232,997,000USD—-221,702,000USD221,963,000USD-220,923,000USD
    Unclassified Investing Cash Flow———-483,364,000USD17,486,000USD——-27,656,000USD
    Unclassified Operating Cash Flow———————-7,231,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income168,024,000USD28,507,000USD-237,892,000USD-291,754,000USD-287,100,000USD132,244,000USD89,833,000USD-209,409,000USD
    Depreciation3,924,000USD5,276,000USD3,791,000USD3,699,000USD3,454,000USD2,888,000USD3,259,000USD3,235,000USD
    Stock Based Compensation16,966,000USD27,802,000USD43,110,000USD50,737,000USD51,364,000USD38,160,000USD33,591,000USD34,797,000USD
    Other Non Cash Items-321,585,000USD-137,919,000USD52,933,000USD75,451,000USD143,052,000USD15,504,000USD15,655,000USD-1,746,000USD
    Change To Account Receivables93,557,000USD149,350,000USD-150,683,000USD13,052,000USD34,062,000USD-15,218,000USD-141,992,000USD8,278,000USD
    Change To Inventory-17,108,000USD-31,952,000USD-46,734,000USD-47,348,000USD-6,253,000USD-38,359,000USD-48,184,000USD-5,484,000USD
    Change In Working Capital-5,842,000USD55,894,000USD-36,826,000USD-79,257,000USD42,360,000USD-34,651,000USD-113,928,000USD10,297,000USD
    Total Cash From Operating Activities-138,513,000USD-20,440,000USD-174,884,000USD-241,124,000USD-37,432,000USD154,145,000USD28,355,000USD-159,266,000USD
    Capital Expenditures0USD0USD-286,000USD-2,039,000USD-1,289,000USD-7,231,000USD-12,897,000USD-789,000USD
    Free Cash Flow-138,513,000USD-20,440,000USD-175,170,000USD-243,163,000USD-38,721,000USD146,914,000USD15,458,000USD-160,055,000USD
    Investments-82,376,000USD230,321,000USD144,640,000USD-127,382,000USD-1,121,000USD155,000USD165,000USD1,000USD
    Total Cashflows From Investing Activities375,087,000USD230,321,000USD144,640,000USD-166,850,000USD-138,410,000USD-14,401,000USD-12,732,000USD-1,188,000USD
    Net Borrowings-280,837,000USD-223,408,000USD0USD49,929,000USD-672,000USD222,156,000USD72,955,000USD72,955,000USD
    Total Cash From Financing Activities-273,705,000USD-186,974,000USD69,600,000USD54,326,000USD51,879,000USD223,946,000USD89,370,000USD105,421,000USD
    Issuance Of Capital Stock7,894,000USD1,455,000USD71,718,000USD6,358,000USD40,903,000USD40,903,000USD8,153,000USD101,748,000USD
    Change In Cash-37,131,000USD22,907,000USD39,344,000USD-353,648,000USD-123,963,000USD363,690,000USD104,717,000USD-54,565,000USD
    Begin Period Cash Flow126,250,000USD103,343,000USD63,547,000USD417,635,000USD541,598,000USD177,908,000USD73,191,000USD127,756,000USD
    End Period Cash Flow89,119,000USD126,250,000USD102,891,000USD63,987,000USD417,635,000USD541,598,000USD177,908,000USD73,191,000USD
    Other Cashflows From Investing Activities457,463,000USD215,433,000USD5,946,000USD-37,429,000USD-137,289,000USD-7,325,000USD-1,657,000USD301,000USD
    Other Cashflows From Financing Activities-48,767,000USD34,979,000USD-4,621,000USD-1,961,000USD11,648,000USD1,790,000USD8,262,000USD3,673,000USD
    Unclassified Financing Cash Flow48,005,000USD—77,808,000USD13,846,000USD44,409,000USD21,229,000USD81,108,000USD25,120,000USD
    Unclassified Investing Cash Flow—-215,433,000USD-5,660,000USD———1,657,000USD—
    Sale Purchase Of Stock——-3,587,000USD-3,744,000USD-1,753,000USD-880,000USD-815,000USD3,673,000USD
    Change To Liabilities———-2,757,000USD18,576,000USD2,827,000USD30,284,000USD7,573,000USD
    Dividends Paid———-3,744,000USD-1,753,000USD-20,349,000USD-72,140,000USD—
    Cash And Cash Equivalents Changes———-353,648,000USD-123,963,000USD363,690,000USD104,993,000USD-55,033,000USD
    Unclassified Operating Cash Flow————9,438,000USD——3,560,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductProduct And Service Other694,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductToripalimab13,613,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductProduct And Service Other507,000USD0001104659-26-058703
    Q1 2026Quarterly · 2026-03-31ProductToripalimab11,803,000USD0001104659-26-058703
    Q4 2025Quarterly · 2025-12-31ProductProduct And Service Other388,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductToripalimab12,360,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductProduct And Service Other1,336,000USD0001104659-26-025308
    FY 2025Yearly · 2025-12-31ProductToripalimab40,836,000USD0001104659-26-025308
    Q3 2025Quarterly · 2025-09-30ProductProduct And Service Other402,000USD0001104659-25-107852
    Q3 2025Quarterly · 2025-09-30ProductToripalimab11,169,000USD0001104659-25-107852
    Q2 2025Quarterly · 2025-06-30ProductProduct And Service Other295,000USD0001558370-25-010803
    Q2 2025Quarterly · 2025-06-30ProductToripalimab9,959,000USD0001558370-25-010803
    Q1 2025Quarterly · 2025-03-31ProductProduct And Service Other251,000USD0001104659-26-058703
    Q1 2025Quarterly · 2025-03-31ProductToripalimab7,348,000USD0001104659-26-058703
    Q4 2024Quarterly · 2024-12-31ProductProduct And Service Other211,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductToripalimab7,522,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductProduct And Service Other7,258,000USD0001104659-26-025308
    FY 2024Yearly · 2024-12-31ProductToripalimab19,131,000USD0001104659-26-025308
    Q3 2024Quarterly · 2024-09-30ProductProduct And Service Other220,000USD0001104659-25-107852
    Q3 2024Quarterly · 2024-09-30ProductToripalimab5,832,000USD0001104659-25-107852
    FY 2023Yearly · 2023-12-31ProductCimerli125,388,000USD0001558370-25-003126
    FY 2023Yearly · 2023-12-31ProductProduct And Service Other664,000USD0001558370-25-003126
    FY 2023Yearly · 2023-12-31ProductToripalimab554,000USD0001558370-25-003126
    FY 2023Yearly · 2023-12-31ProductUdenyca127,064,000USD0001558370-25-003126
    FY 2023Yearly · 2023-12-31ProductYusimry3,574,000USD0001558370-25-003126
    FY 2022Yearly · 2022-12-31ProductCimerli6,946,000USD0001558370-25-003126
    FY 2022Yearly · 2022-12-31ProductProduct And Service Other282,000USD0001558370-25-003126
    FY 2022Yearly · 2022-12-31ProductUdenyca203,814,000USD0001558370-25-003126
    FY 2021Yearly · 2021-12-31ProductProduct326,509,000USD0001558370-24-003436
    FY 2021Yearly · 2021-12-31ProductProduct And Service Other42,000USD0001558370-24-003436
    FY 2019Yearly · 2019-12-31ProductLicense And Service0USD0001564590-20-007416
    FY 2019Yearly · 2019-12-31ProductProduct356,100,000USD0001564590-20-007416
    FY 2019Yearly · 2019-12-31GeographyInternational0USD0001564590-20-007416
    FY 2019Yearly · 2019-12-31GeographyUnited States356,071,000USD0001564590-20-007416
    FY 2017Yearly · 2017-12-31ProductLicense And Service1,556,000USD0001564590-20-007416
    FY 2017Yearly · 2017-12-31ProductProduct0USD0001564590-20-007416
    FY 2017Yearly · 2017-12-31GeographyInternational1,556,000USD0001564590-20-007416
    FY 2017Yearly · 2017-12-31GeographyUnited States0USD0001564590-20-007416
    FY 2016Yearly · 2016-12-31GeographyInternational1,814,000USD0001564590-19-005470
    FY 2016Yearly · 2016-12-31GeographyUnited States188,292,000USD0001564590-19-005470
    Q4 2016Quarterly · 2016-12-31GeographyInternational844,000USDLegacy provider
    Q4 2016Quarterly · 2016-12-31GeographyUnited States0USDLegacy provider
    Q3 2016Quarterly · 2016-09-30GeographyInternational298,000USD0001564590-17-021844
    Q3 2016Quarterly · 2016-09-30GeographyUnited States162,537,000USD0001564590-17-021844
    Q2 2016Quarterly · 2016-06-30GeographyInternational318,000USD0001564590-17-016017
    Q2 2016Quarterly · 2016-06-30GeographyUnited States13,750,000USD0001564590-17-016017
    Q1 2016Quarterly · 2016-03-31GeographyInternational354,000USD0001564590-17-009394
    Q1 2016Quarterly · 2016-03-31GeographyUnited States12,005,000USD0001564590-17-009394
    FY 2015Yearly · 2015-12-31GeographyInternational2,239,000USD0001564590-18-004947
    FY 2015Yearly · 2015-12-31GeographyUnited States27,802,000USD0001564590-18-004947
    Q2 2015Quarterly · 2015-06-30GeographyInternational387,000USD0001564590-16-023684
    Q2 2015Quarterly · 2015-06-30GeographyUnited States6,479,000USD0001564590-16-023684
    Q1 2015Quarterly · 2015-03-31GeographyInternational497,000USD0001564590-16-018615
    Q1 2015Quarterly · 2015-03-31GeographyUnited States5,313,000USD0001564590-16-018615
    FY 2014Yearly · 2014-12-31GeographyInternational2,625,000USD0001564590-17-004176
    FY 2014Yearly · 2014-12-31GeographyUnited States28,481,000USD0001564590-17-004176
    FY 2013Yearly · 2013-12-31GeographyInternational2,025,000USD0001564590-16-013726
    FY 2013Yearly · 2013-12-31GeographyUnited States726,000USD0001564590-16-013726
    Q2 2012Quarterly · 2012-04-28SegmentCorporate Elimination0USD0000019353-12-000034
    Q2 2012Quarterly · 2012-04-28SegmentDirect To Consumer15,292,000USD0000019353-12-000034
    Q2 2012Quarterly · 2012-04-28SegmentRetail Stores465,971,000USD0000019353-12-000034
    FY 2012Yearly · 2012-01-28SegmentCorporate Elimination0USD0000019353-12-000012
    FY 2012Yearly · 2012-01-28SegmentDirect To Consumer121,329,000USD0000019353-12-000012
    FY 2012Yearly · 2012-01-28SegmentRetail Stores1,871,042,000USD0000019353-12-000012
    Q4 2011Quarterly · 2011-10-29SegmentCorporate Elimination0USD0000019353-11-000075
    Q4 2011Quarterly · 2011-10-29SegmentDirect To Consumer11,990,000USD0000019353-11-000075
    Q4 2011Quarterly · 2011-10-29SegmentRetail Stores417,721,000USD0000019353-11-000075
    Q3 2011Quarterly · 2011-07-30SegmentCorporate Elimination0USD0000019353-11-000058
    Q3 2011Quarterly · 2011-07-30SegmentDirect To Consumer6,424,000USD0000019353-11-000058
    Q3 2011Quarterly · 2011-07-30SegmentRetail Stores492,778,000USD0000019353-11-000058
    Q2 2011Quarterly · 2011-04-30SegmentCorporate Elimination0USD0000019353-12-000034
    Q2 2011Quarterly · 2011-04-30SegmentDirect To Consumer13,772,000USD0000019353-12-000034
    Q2 2011Quarterly · 2011-04-30SegmentRetail Stores490,581,000USD0000019353-12-000034
    FY 2011Yearly · 2011-01-29SegmentCorporate Elimination0USD0000019353-12-000012
    FY 2011Yearly · 2011-01-29SegmentDirect To Consumer115,151,000USD0000019353-12-000012
    FY 2011Yearly · 2011-01-29SegmentRetail Stores1,946,668,000USD0000019353-12-000012
    Q4 2010Quarterly · 2010-10-30SegmentCorporate Elimination0USD0000019353-11-000075
    Q4 2010Quarterly · 2010-10-30SegmentDirect To Consumer9,718,000USD0000019353-11-000075
    Q4 2010Quarterly · 2010-10-30SegmentRetail Stores453,901,000USD0000019353-11-000075
    Q3 2010Quarterly · 2010-07-31SegmentCorporate Elimination0USD0000019353-11-000058
    Q3 2010Quarterly · 2010-07-31SegmentDirect To Consumer5,345,000USD0000019353-11-000058
    Q3 2010Quarterly · 2010-07-31SegmentRetail Stores512,219,000USD0000019353-11-000058
    FY 2010Yearly · 2010-01-30SegmentCorporate Elimination426,000USD0000019353-12-000012
    FY 2010Yearly · 2010-01-30SegmentDirect To Consumer116,630,000USD0000019353-12-000012
    FY 2010Yearly · 2010-01-30SegmentRetail Stores1,947,546,000USD0000019353-12-000012

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.